However, in PC xenograft models, some authors found that the co-administration of an armed oncolytic adenovirus with a helper-dependent adenovirus expressing a PD-L1 blocking mini-antibody may enhance the antitumor effects of CAR T-cells, producing PD-L1 mini-bodies at the tumor site: further data are required [143]. This evidence concerns the gene CD274 and neoplasm.